MSOS News and Press, AdvisorShares Trust Pure US Cannabis From 04/30/24

2024-04-30 14:15:33 ET More on cannabis ETFs MSOS: 4/20 Is Cannabis Day - Significant Implications For Investors MJ: Over Diversified Cannabis ETF, But Still A Solid Pick Why Is The MSOS Cannabis ETF Soaring Again? Rescheduling May Be 'Imminent' DEA to resche...

2024-04-30 13:17:48 ET More on cannabis ETFs MSOS: 4/20 Is Cannabis Day - Significant Implications For Investors MJ: Over Diversified Cannabis ETF, But Still A Solid Pick Why Is The MSOS Cannabis ETF Soaring Again? Rescheduling May Be 'Imminent' Marijuana res...

2024-04-30 11:11:29 ET More on Cannabis ETFs MSOS: 4/20 Is Cannabis Day - Significant Implications For Investors MJ: Over Diversified Cannabis ETF, But Still A Solid Pick Why Is The MSOS Cannabis ETF Soaring Again? Rescheduling May Be 'Imminent' Cannabis stoc...

2024-04-25 13:29:58 ET More on cannabis-related ETFs MSOS: 4/20 Is Cannabis Day - Significant Implications For Investors MJ: Over Diversified Cannabis ETF, But Still A Solid Pick Why Is The MSOS Cannabis ETF Soaring Again? Rescheduling May Be 'Imminent' White...

2024-04-21 13:02:41 ET Summary Organigram stock has performed well this year, despite an equity raise and a temporary pullback caused by Tilray's poor financial report. The fiscal Q1 report showed a revenue shortfall, particularly in international sales, but positive operating cas...

2024-04-20 08:00:00 ET Summary April 20th could be a critical turning point for US-based cannabis stocks as investors await potential regulatory reform. The MSOS ETF offers a highly liquid way to invest in US-based cannabis operators. Rescheduling cannabis to Schedule III and ...

2024-04-16 10:13:42 ET More on cannabis stocks Investors Have Another Chance To Sell Curaleaf Why Is The MSOS Cannabis ETF Soaring Again? Rescheduling May Be 'Imminent' Curaleaf: New York To The Rescue Marijuana banking legislation could be attached to crypto...

2024-04-14 08:08:28 ET Summary Verano Holdings has rallied since November, gaining 15.5%, but underperforming its peers in the cannabis industry. The company's Q4 financials fell short of expectations, with revenue rising just 5% and adjusted EBITDA dropping 7%. Analysts have ...

2024-04-13 07:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-11 15:38:27 ET More on Ayr Wellness, Trulieve Cannabis, etc. Tilray Brands, Inc. (TLRY) Q3 2024 Earnings Call Transcript Tilray Brands Q3 Earnings: Another Disappointing Quarter Tilray Could Break Down Tilray guidance cut sends cannabis stocks lower ...